Trial Profile
A Placebo-Controlled, Double-Blind, Cross-Over Study With Rupatadine 10 Mg in 30 Mosquito-Bite Allergic Adult Subjects
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 20 Jan 2020
Price :
$35
*
At a glance
- Drugs Rupatadine (Primary)
- Indications Hypersensitivity
- Focus Therapeutic Use
- Sponsors Uriach
- 01 Feb 2017 New trial record